Karin Garming-Legert

Publications
CV
Public outreach and news

Articles

Article: ORAL DISEASES. 2023;29(8):3346-3359

Immunohistopathology of oral mucosal chronic graft-versus-host disease severity and duration.

Tollemar V; Ström J; Tudzarovski N; Häbel H; Legert KG; Heymann R; Warfvinge G; Le Blanc K; Sugars RV
Article: HELIYON. 2023;9(4):e15517

Grading of minor salivary gland immuno-histopathology post-allogenic hematopoietic cell transplantation.

Tollemar V; Arvidsson H; Häbel H; Tudzarovski N; Legert KG; Le Blanc K; Warfvinge G; Sugars RV
Article: PLOS ONE. 2023;18(5):e0285615

Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study.

Skallsjö K; von Bültzingslöwen I; Hasséus B; Johansson J-E; Öhman J; Raber-Durlacher JE; Huysmans M-CDNJM; Laheij AMGA; van Leeuwen SJM; Hovan AJ; Garming Legert K; Nguyen HM; Turk PJ; Rozema FR; Blijlevens NMA; Brennan MT
Article: FRONTIERS IN ORAL HEALTH. 2023;4:1087761

Dental health of patients with X-linked hypophosphatemia: A controlled study.

Larsson A; Regnstrand T; Skott P; Mäkitie O; Björnsdottir S; Garming-Legert K
Article: BONE MARROW TRANSPLANTATION. 2022;57(2):191-197

Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial.

Walladbegi J; Henriksson R; Tavelin B; Svanberg A; Larfors G; Jädersten M; Schjesvold F; Mahdi A; Garming Legert K; Peterson DE; Jontell M
Article: ORAL DISEASES. 2021;27(5):1217-1225

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis.

Garming Legert K; Ringdén O; Remberger M; Törlén J; Mattsson J; Dahllöf G
Article: SUPPORTIVE CARE IN CANCER. 2020;28(10):4869-4879

Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial.

Kamsvåg T; Svanberg A; Legert KG; Arvidson J; von Essen L; Mellgren K; Toporski J; Winiarski J; Ljungman G
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2020;26(10):1971-1979

Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis.

Tollemar V; Tudzarovski N; Warfvinge G; Yarom N; Remberger M; Heymann R; Garming Legert K; Sugars RV
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2020;9(10):1190-1202

Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study.

Boberg E; von Bahr L; Afram G; Lindström C; Ljungman P; Heldring N; Petzelbauer P; Garming Legert K; Kadri N; Le Blanc K
Article: VOX SANGUINIS. 2019;114(7):769-777

Granulocyte transfusions could benefit patients with severe oral mucositis after allogeneic hematopoietic stem cell transplantation.

Berglund S; Watz E; Remberger M; Garming Legert K; Axdorph-Nygell U; Sundin M; Uhlin M; Mattsson J
Article: CYTOMETRY PART B-CLINICAL CYTOMETRY. 2018;93(10):1051-1059

Quantitative chromogenic immunohistochemical image analysis in cellprofiler software.

Tollemar V; Tudzarovski N; Boberg E; Törnqvist Andrén A; Al-Adili A; Le Blanc K; Garming Legert K; Bottai M; Warfvinge G; Sugars RV
Article: JMIR RESEARCH PROTOCOLS. 2018;7(4):e103

Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study.

Brennan MT; Hasséus B; Hovan AJ; Raber-Durlacher JE; Blijlevens NM; Huysmans M-C; Garming Legert K; Johansson J-E; Moore CG; von Bültzingslöwen I
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2017;106(4):471-475

Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.

Remberger M; Törlen J; Serafi IE; Garming-Legert K; Björklund A; Ljungman P; Sundin M; Hassan M; Mattsson J
Article: HAEMATOLOGICA. 2016;101(11):1417-1425

A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.

Törlén J; Ringdén O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itälä-Remes M; Remberger M; Mattsson J
Journal article: BLOOD. 2015;126(23):3138

Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study

Von Bahr L; Davies L; Afram G; Modin C; Garming-Legert K; Hagglund H; Ljungman PT; Le Blanc K
Article: SUPPORTIVE CARE IN CANCER. 2015;23(6):1749-1757

The relationship between oral mucositis and levels of pro-inflammatory cytokines in serum and in gingival crevicular fluid in allogeneic stem cell recipients.

Legert KG; Tsilingaridis G; Remberger M; Ringdèn O; Heimdahl A; Yucel-Lindberg T; Dahllöf G
Article: SUPPORTIVE CARE IN CANCER. 2014;22(8):2133-2140

Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.

Legert KG; Remberger M; Ringdén O; Heimdahl A; Dahllöf G
Article: BLOOD. 2014;124(5):812-821

Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

Munneke JM; Björklund AT; Mjösberg JM; Garming-Legert K; Bernink JH; Blom B; Huisman C; van Oers MHJ; Spits H; Malmberg K-J; Hazenberg MD
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(2):153-162

A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation.

Ringdén O; Erkers T; Aschan J; Garming-Legert K; Le Blanc K; Hägglund H; Omazic B; Svenberg P; Dahllöf G; Mattsson J; Ljungman P; Remberger M
Article: BONE MARROW TRANSPLANTATION. 2012;47(3):404-410

Salivary secretion in children after fractionated or single-dose TBI.

Garming Legert K; Remberger M; Ringdèn O; Heimdahl A; Dahllöf G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(6):503-509

Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders.

Ringdén O; Remberger M; Dahllöf G; Garming-Legert K; Karlsson H; Svenberg P; Uhlin M; Uzunel M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697

Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study.

Remberger M; Ackefors M; Berglund S; Blennow O; Dahllöf G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hägglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikström A-C; Winiarski J; Ringdén O
Article: ORAL DISEASES. 2011;17(7):670-676

Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI.

Garming-Legert K; Remberger M; Ringdén O; Hassan M; Dahllöf G
Article: ORAL ONCOLOGY. 2011;47(9):915-919

Xerostomia in children and adolescents after stem cell transplantation conditioned with total body irradiation or busulfan.

Dahllöf G; Wondimu B; Barr-Agholme M; Garming-Legert K; Remberger M; Ringdén O
Article: ACTA OTO-LARYNGOLOGICA. 2005;125(11):1195-1202

Development and characterization of an animal model of dental sinusitis.

Legert KG; Melén I; Heimdahl A; Stierna P
Show more

All other publications

Review: FRONTIERS IN IMMUNOLOGY. 2023;14:1151493

Perspectives on oral chronic graft-versus-host disease from immunobiology to morbid diagnoses.

Tollemar V; Garming Legert K; Sugars RV
Letter: CYTOTHERAPY. 2018;20(5):755-758

Stromal progenitor cell modulation by thalidomide in the treatment of oral chronic graft-versus-host disease.

Davies LC; Board-Davies E; Shamlou B; Boberg E; Garming-Legert K; Le Blanc K
Preprint: JMIR PREPRINTS. 2017

Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study (Preprint)

Brennan MT; Hasséus B; Hovan AJ; Raber-Durlacher JE; Blijlevens NM; Huysmans M-C; Garming Legert K; Johansson J-E; Moore CG; von Bültzingslöwen I
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):285

Thymic function predicts response to mesenchymal stromal cell treatment in chronic GVHD

Boberg E; von Bahr L; Heldring N; Afram G; Iacobaeus E; Modin C; Garming-Legert K; Ljungman P; Sugars R; Davies L; Kadri N; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2017;52:S234

The role of stromal dysfunction in oral chronic GVHD

Davies L; Boberg E; Board-Davies E; Shamlou B; Garming-Legert K; Le Blanc K
Conference publication: BLOOD. 2017;130

Thymic Function Predicts Response to Mesenchymal Stromal Cell Treatment in Chronic GvHD: A Phase II Clinical Study

Boberg E; Von Bahr L; Heldring N; Afram G; Iacobaeus E; Lindstrom C; Garming-Legert K; Ljungman P; Sugars R; Davies L; Kadri N; Le Blanc K
Conference publication: PEDIATRIC BLOOD & CANCER. 2017;64:S360-S361

Oral Cryotherapy to Reduce the Incidence of Severe Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation: Results of a Randomized Clinical Trial

Magnusson TK; von Essen L; Arvidson J; Svanberg A; Mellgren K; Garming-Legert K; Toporski J; Winiarski J; Ljungman G
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S21

A prospective randomized study comparing tacrolimus and sirolimus versus cyclosporine and methotrexate as gvhd prophylaxis in allogeneic hematopoietic stem cell transplantation

Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Letter: ORAL ONCOLOGY. 2015;51(12):e97-e99

Enhanced oral healing following local mesenchymal stromal cell therapy.

Garming-Legert K; Tour G; Sugars R; von Bahr L; Davies LC; Le Blanc K
Review: SUPPORTIVE CARE IN CANCER. 2015;23(1):223-236

Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT).

Elad S; Raber-Durlacher JE; Brennan MT; Saunders DP; Mank AP; Zadik Y; Quinn B; Epstein JB; Blijlevens NMA; Waltimo T; Passweg JR; Correa MEP; Dahllöf G; Garming-Legert KUE; Logan RM; Potting CMJ; Shapira MY; Soga Y; Stringer J; Stokman MA; Vokurka S; Wallhult E; Yarom N; Jensen SB
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S501

BASIC ORAL CARE FOR HEMATOLOGY-ONCOLOGY PATIENTS AND HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS: A POSITION PAPER FROM THE JOINT TASK FORCE OF MASCC/ISOO AND EBMT

Mank A; Quinn B; Wallhult E; Raber-Durlacher J; Elad S; Brennan MT; Saunders DP; Zadik Y; Epstein JB; Blijlevens NM; Waltimo T; Passweg JR; Correa MEP; Dahllof G; Garming-Legert KU; Logan RM; Potting CM; Shapira MY; Soga Y; Stringer J; Stokman MA; Vokurka S; Yarom N; Jensen SB
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(2):S280-S281

EFFECT OF BUSULFAN AND TOTAL BODY IRRADIATION ON DENTAL DEVELOPMENT AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDHOOD

Dahllof G; Wondimu B; Garming-Legert K; Remberger M; Ringden O
Thesis / dissertation: 2011

Conditioning associated effects on oral mucosa and salivary function in allogeneic stem cell recipients

Garming Legert, Karin
Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S167-S168

Improved survival after allogeneic haematopoietic stem cell transplantation in recent years

Ringden O; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S81

Dental development in children after conditioning with busulfan or total body irradiation

Dahlloef G; Garming-Legert K; Remberger M; Ringden O
Review: ACTA OTO-LARYNGOLOGICA. 2004;124(6):655-663

Sinusitis of odontogenic origin: pathophysiological implications of early treatment.

Legert KG; Zimmerman M; Stierna P

Employments

Lecturer/Senior Dentist, Department of Dental Medicine, Karolinska Institutet, 2019-

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Dental Medicine, Karolinska Institutet, 2011

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI